Direct Stereoselective Method Development and Validation of Elagolix on Zwitterionic Chiral Stationary Phase by High-Pressure Liquid Chromatography
Abstract
A specific, sensitive and accurate chiral technique has been developed for the quantification of elagolix enantiomer in a drug product. The present research work represents the development and validation of chromatographic technique for the separation of elagolix enantiomers on a chiral stationary phase (CSP) comprising a zwitterionic selector derived from cinchona alkaloid and sulfonic acid CHIRALPAK ZWIX (+) under isocratic condition containing 50mM Acetic acid and 25mM diethyl amine in water and methanol in the ratio of 02:98 v/v with 0.5 ml min-1 flow rate. Temperature of the column was monitored at 40°C with a resolving factor more than 3.2. The eluted compounds were monitored at 275 nm. The optimized method has high degree of selectivity with lower limiting values of detection and quantitation and were found to be 2.0 ng/ml and 7.5 ng/ml, respectively for the enantiomeric chiral impurity. The developed method was subjected for validation as per the ICH guidelines, produced good findings regarding specificity, accuracy, precision, robustness and linearity.
Keywords:
Elagolix, GnRH antagonist, CHIRALPAK ZWIX ( ), Validation, Enantiomer.DOI
https://doi.org/10.25004/IJPSDR.2020.120513References
Tukun FL, Olberg DE, Riss PJ, Haraldsen I, Kaass A, Klaveness J. Recent development of non-peptide GnRH antagonists. Molecules. 2017; 22(12): 188.
Struthers RS, Nicholls AJ, Grundy J, Chen T, Jimenez R, Yen SS, Bozigian HP. Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix, J. Clin. Endocrinol. Metab. 2009;94(2): 545–51.
Ezzati Mohammad, Carr Bruce R. Elagolix, a novel, orally bioavailable GnRH antagonist under investigation for the treatment of endometriosis-related pain. Women's Health. 2015; 11(1):19–28.
Orilissa (elagolix) Health Canada Product Monograph (PDF). 4 October 2018. Retrieved 15 February 2019.
Lamb YN. Elagolix: First Global Approval. Drugs. 2018; 78(14):1501–1508.
Clemenza S, Sorbi F, Noci I, Capezzuoli T, Turrini I, Carriero C, Buffi N, Fambrini M, Petraglia F. From pathogenesis to clinical practice: Emerging medical treatments for endometriosis. Best Pract Res Clin Obstet Gynaecol. 2018; 51:92–101.
Melis GB, Neri M, Corda V, Malune ME, Piras B, Pirarba S, Guerriero S, Orru M, D'Alterio MN, Angioni S, Paoletti AM. Overview of elagolix for the treatment of endometriosis. Expert Opin Drug Metab Toxicol. 2016; 12(5):581-8.
Giudice LC. Clinical practice, Endometriosis. N Engl J Med. 2010; 362(25): 2389-98.
Nnoaham KE, Hummelshoj L, Webster P, d'Hooghe T, de Cicco Nardone F, de Cicco Nardone C, Jenkinson C, Kennedy SH, Zondervan KT. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011; 96(2);366-373.
ICH Q2 (R1); Validation of Analytical Procedures: Text and Methodology; (2005).
Tong Z, Dung N, Pilar F. Development and validation of the chiral HPLC method for daclatasvir in gradient elution mode on amylose-based immobilized chiral stationary phase. J Chromatogr. A. 2008; 1191: 214–222.
Morante-Zarcero S, Sierra I. Comparative HPLC methods for β-blockers separation using different types of chiral stationary phases in normal phase and polar organic phase elution modes. Analysis of propranolol enantiomers in natural waters. J Pharm Biomed Anal. 2012; 62: 33–41.
Rahman Asma, Mohammad Rashedul Haque, Muhibur Rahman M, Mohammad Rashid A. Enantiomeric determination of carvedilol by a newly developed and validated chiral HPLC method. J Pharm Sci. 2019; 16:165-172.
Kunath A, Theil F, Jähnisch K. Influence of the kind of the alcoholic modifier on chiral separation on a Chiralpak AD column. Journal of Chromatography A. 1996; 728(1-2): 249–257.
Jin JY, Bae SK, Lee W. Comparative studies between covalently immobilized and coated chiral stationary phases based on polysaccharide derivatives for enantiomer separation of N-protected α-amino acids and their ester derivatives. Chirality. 2009; 21(10): 871-877.
Toussaint B, Duchateau, Vanderwal S, Albert A, Hubert P, Crommen J. Determination of the enantiomers of 3-tertbutylamino-1,2-propanediol by high performance liquid chromatography coupled to evaporative light scattering detection. J Chromatogr. A. 2000; 890(2): 239–249.
Hoffmann CV, Pell R, Lämmerhofer M, Lindner W. Synergistic effects on enantioselectivity of zwitterionic chiral stationary phases for separations of chiral acids, bases, and amino acids by HPLC, Anal. Chem. 2008; 80:8780–8789.
Zhang T, Holder E, Franco P, Lindner W. Zwitterionic chiral stationary phases based on cinchona and chiral sulfonic acids for the direct stereoselective separation of amino acids and other amphoteric compounds. J. Sep. Sci. 2014;37(11): 1237–1247.
Zhang T, Holder E, Franco P, Lindner W. Method development and optimization on cinchona and chiral sulfonic acid-based zwitterionic stationary phases for enantiomer separations of amino acids by high-performance liquid chromatography. J. Chromatogr. A. 2014; 1363: 191–199.
Published
Abstract Display: 673 
PDF Downloads: 567 
